Search
Serabelisib
go.drugbank.com/drugs/DB14935InvestigationalSerabelisib is under investigation in clinical trial NCT02625259 (A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics
BT200
go.drugbank.com/drugs/DB18333Investigational[A261491] It is under investigation for the treatment of von Willebrand disease and hemophilia A.[L48156]
ABT-072
go.drugbank.com/drugs/DB15156InvestigationalABT-072 is under investigation in clinical trial NCT00890318 (A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat
Peralopride
go.drugbank.com/drugs/DB20064ExperimentalThe usage of the INN stem '-pride' in the name indicates that Peralopride is a sulpiride derivative and analogue. Peralopride has a monoisotopic molecular weight of 403.13 Da.
Dazopride
go.drugbank.com/drugs/DB20559ExperimentalThe usage of the INN stem '-pride' in the name indicates that Dazopride is a sulpiride derivative and analogue. Dazopride has a monoisotopic molecular weight of 326.15 Da.
Dobupride
go.drugbank.com/drugs/DB20688ExperimentalThe usage of the INN stem '-pride' in the name indicates that Dobupride is a sulpiride derivative and analogue. Dobupride has a monoisotopic molecular weight of 411.19 Da.
Trazolopride
go.drugbank.com/drugs/DB20942ExperimentalThe usage of the INN stem '-pride' in the name indicates that Trazolopride is a sulpiride derivative and analogue. Trazolopride has a monoisotopic molecular weight of 365.19 Da.
Cloxacepride
go.drugbank.com/drugs/DB21428ExperimentalThe usage of the INN stem '-pride' in the name indicates that Cloxacepride is a sulpiride derivative and analogue. Cloxacepride has a monoisotopic molecular weight of 467.14 Da.
Etriciguat
go.drugbank.com/drugs/DB20610ExperimentalThe usage of the INN stem '-ciguat' in the name indicates that Etriciguat is a guanylate cyclase activator and stimulator. Etriciguat has a monoisotopic molecular weight of 397.15 Da.